Menu
Not yet recruiting NCT05184829

A Single-center Study on the Effect of Systemic/Selective Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With Components With Consolidation/Tumor Ratio Between 0.5-1

No phase Interventional Progression Postoperative Recovery

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: selective lymph node dissection, Systemic Lymph Node Dissection.
Who it may be relevant to
Registry conditions: Progression, Postoperative Recovery. Basic parameters: 25 years — 75 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

A single-center study on the effect of systemic/selective lymph node dissection on the prognosis of ground glass nodules smaller than 3cm and with components with consolidation/tumor ratio between 0.5-1

Detailed description

A single-center study on the effect of systemic/selective lymph node dissection on the prognosis of ground glass nodules smaller than 3cm and with components with consolidation/tumor ratio between 0.5-1

Interventions

  • Other selective lymph node dissection
    selective lymph node dissection
  • Other Systemic Lymph Node Dissection
    Systemic Lymph Node Dissection

Primary outcome measures

  • Overall survival [Time frame: From enrollment to 36 months after surgery]
Secondary outcome measures (1)
  • Complications [Time frame: 1-2 Weeks after enrollment (after Surgery)]

Eligibility criteria

Inclusion criteria

Patients enrolled in the study must meet all of the following conditions:

  • 1.Aged between 25 and 75 years;
  • 2\. GGO is diagnosed by thin-section lung CT (thickness <1.5mm) within one month before surgery;
  • 3\. The maximum diameter of the GGO is smaller than 3cm;
  • 4\. The solid component in GGO between 50%-100%;
  • 5\. Preoperative examination showed that the patient could tolerate lobectomy;
  • 6\. The patient is able to understand and comply with the study and has provided written informed consent.

Exclusion criteria

Patients meeting any of the following criteria are not eligible for this trial:

  • 1\. Patients with a history of lung surgery;
  • 2\. Postoperative pathology showed non-primary lung cancer;
  • 3\. The scope of surgical resection is larger than one lung lobe;
  • 4\. Patients with a history of other tumors;
  • 5\. Patients with severe complications (coronary heart disease, valvular heart disease, end-stage renal disease, severe liver cirrhosis);
  • 6\. Unable to cooperate with the researchers because of dementia or cognitive decline
  • 7\. Other situations that are not in conformity with the standards and requirements of this trial.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Other

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT05184829 · B2021

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗